Authors Pharaon M, Tichet M, Lebrun-Frénay C, Tartare-Deckert S, Passeron T
JAMA dermatology Jun 2014
Is it time to test biguanide metformin in the treatment of melanoma?Authors Cerezo M, Tomic T, Ballotti R, Rocchi S
Pigment cell & melanoma research Jun 2014
Oxytocin reverses ovariectomy-induced osteopenia and body fat gain.Authors Beranger GE, Pisani DF, Castel J, Djedaini M, Battaglia S, Amiaud J, Boukhechba F, Ailhaud G, Michiels JF, Heymann D, Luquet S, Amri EZ
Endocrinology Feb 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.Authors Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, Lipson D, Otto G, Brennan K, Murali R, Garrido M, Miller VA, Ross JS, Berger MF, Sparatta A, Palmedo G, Cerroni L, Busam KJ, Kutzner H, Cronin MT, Stephens PJ, Bastian BC
Nature communications Jan 2014
Mitochondrial oxidative stress is the Achille’s heel of melanoma cells resistant to Braf-mutant inhibitor.Authors Corazao-Rozas P, Guerreschi P, Jendoubi M, André F, Jonneaux A, Scalbert C, Garçon G, Malet-Martino M, Balayssac S, Rocchi S, Savina A, Formstecher P, Mortier L, Kluza J, Marchetti P
Oncotarget Oct 2013
Chondrogenic potential of stem cells derived from adipose tissue: a powerful pharmacological tool.Authors Roux C, Pisani DF, Yahia HB, Djedaini M, Beranger GE, Chambard JC, Ambrosetti D, Michiels JF, Breuil V, Ailhaud G, Euller-Ziegler L, Amri EZ
Biochemical and biophysical research communications Oct 2013
Vitamin D in pregnancy and early life: the right target for prevention of allergic disease?Authors Tulic MK
Expert review of clinical immunology Sep 2013
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.Authors Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC
Pigment cell & melanoma research Aug 2013
Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.Authors Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F, Allegra M, Giacchero D, Bahadoran P, Bertolotto C, Tartare-Deckert S, Ballotti R, Rocchi S
Molecular cancer therapeutics Jun 2013
Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in adipocytes.Authors Regazzetti C, Dumas K, Le Marchand-Brustel Y, Peraldi P, Tanti JF, Giorgetti-Peraldi S
PloS one Dec 2012